Among blood system tumors, the overexpression of Tim3 on leukemic stem cells in acute myeloid leukemia (AML) can activate PI3K/AKT/mTOR and NF-κB signaling pathways (21). The gene discussed is HAVCR2; the disease is acute myeloid leukemia.